Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$4.07 - $8.68 $10,638 - $22,689
-2,614 Reduced 54.82%
2,154 $15,000
Q4 2023

Feb 02, 2024

SELL
$3.71 - $5.14 $34,725 - $48,110
-9,360 Reduced 66.25%
4,768 $23,000
Q3 2023

Nov 01, 2023

BUY
$2.98 - $4.43 $39,985 - $59,441
13,418 Added 1889.86%
14,128 $59,000
Q2 2023

Aug 04, 2023

BUY
$2.76 - $5.27 $1,959 - $3,741
710 New
710 $2,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.